Ignite Creation Date:
2025-12-24 @ 11:58 PM
Ignite Modification Date:
2025-12-25 @ 9:55 PM
Study NCT ID:
NCT05879458
Status:
TERMINATED
Last Update Posted:
2025-07-18
First Post:
2023-05-18
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Ritlecitinib in CTCL
Sponsor:
Icahn School of Medicine at Mount Sinai
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-05-17
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-06-25
Completion Date Type:
ACTUAL
First Submit Date:
2023-05-18
First Submit QC Date:
None
Study First Post Date:
2023-05-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-15
Last Update Post Date:
2025-07-18
Last Update Post Date Type:
ACTUAL